SlideShare ist ein Scribd-Unternehmen logo
1 von 23
Downloaden Sie, um offline zu lesen
•Challenges & Successes
•Malaysia Experience
•NMRR-20-686-54503
SOLIDARITY TRIAL
Dr Chow Ting Soo
Disclaimer
•This slide was prepared for the Webinar Series Demystifying
Clinical Trials & COVID-19 Updates session on 21st July 2021,
by Dr Chow Ting Soo, Consultant Infectious Disease Physician,
Penang General Hospital, Malaysia.
•This is intended to share within healthcare professionals, not for
public.
•Kindly acknowledge “Clinical Updates in COVID-19
http://www.nih.gov.my/covid-19” should you plan to share the
information obtained from this slide with your colleagues.
Introduction
Solidarity is an international clinical trial
To identify effective treatment for COVID-19
Launched by the World Health Organization and
partners
Largest international randomized trials for COVID-19
treatments, enrolling almost 12 000 patients in 500
hospital sites in over 30 countries.
What is Solidarity Trial?
Multi centre , Open label , Randomised
• HCQ
• IFN
• LPV/r
• Remdesivir
Evaluating the effect of drugs vs SOC:
• mortality,
• need for assisted ventilation and
• duration of hospital stay.
On 3 important outcomes in COVID-19 patients:
Why does it work?
Simplified trial procedures
Once approval is obtained (regulatory and ethical),
electronic entry of patients who have given informed
consent
Online randomization of consented patients (via a
cloud-based GCP-compliant clinical data management
system).
Very special design :
•Simple inclusion criteria
•Confirmed COVID-19, hospitalized and consented
•age ≥18 years, not known to have received any
study drug, without anticipated transfer elsewhere
within 72 hours, and, in their physician’s view, with
no contra-indication to any study drug.
•All severity
•Except those critically ill (not able to survive in next
48 – 72H)
•SOC : local guidelines
Unique clinical trial
•The Solidarity Trial is an adaptive trial.
•This means that some unpromising drugs
have been dropped and others will be added.
•Hydroxychloroquine and lopinavir/ritonavir
arms were discontinued on 20 June and 4 July
2020 respectively.
•Interferon was dropped a month later
•Remdesivir vs SOC
Success
•Streamlined trial initiation due to public
emergency
•Fastest ethics clearance by MREC (clearance
given within five days, approved by a Full Board)
•Fast-tracked CTIL clearance by NPRA (clearance
given within seven days, evaluated by 8 reviewers
from NPRA)
•Study grant of RM81,000 was allocated for this
study
•Efficient IMP distribution to site (achieved within
four days, facilitated by Ampang CRC)
Trial timeline
Project Activity Start End Status
1 MREC approval 06/04/2020 10/04/2020 Achieved
2 NPRA approval 10/04/2020 17/04/2020 Achieved
3 IMP distribution to Sites 4/5/2020 8/5/2020 Achieved
Success
•Great support from major hospitals
•Nine major hospitals
•MOH representative Datuk Dr Suresh Kumar+ 9 Principal
investigators +
•62 co-investigators
•Facilitated by researchers Institute of Clinical Research
•Total recruitment: 217 patients
•63 remdesivir, 30 HCQ, 47 lopinavir/ritonavir, 5 interferon,
72 SOC
Team member
HSB
DR Yasmin Gani
Dr Tuang Wei Xuan
Dr Vijayendran Rajalingam
Dr Aruna Karthigayan
Dr Sujana Leon Sean
Saravanamuttu
Dr Suvintheran Thangavelu
Dr Syarifah Nurul Ain bt Syed
Badaruddin
Dr Swarna Lata Krishnabahawan
Puan Rozila binti Harun
Puan Hannah binti Md Mahir
Dr Tharmini A/P Ravi
Hospital KL
DR Leong Chee Loon
Dr Khairil Erwan Khalid
Dr Rasidah bt Senian
Dr Syed Sharif Anwar Aljafri
Dr Suraya Hanim Abdullah Hashim
Dr Shaharudeen bin Kamaludeen
Dr Karina Koh
Dr Lee Jen Ven
Mohamad Ikram Zaki bin Jaafar
Mak Woh Yon
Sim Poh Pei
Dr Nik Nur Eliza binti Mohamed
Team member
Hosp Melaka
DR Nor Zaila
Dr Shalini Vijayasingham
Dr Tay Qin Le
Dr Karamjit Kaur a/p Sarban Singh
Dr Norlizam bin Mohd Nor @ Mat Nor
Delarina Frimawati binti Othman Andu
Dr Siti Hir Md Tahir
Tay Eek Poei
Seri Rabiatul Nur Binti Abu Salim
Hospital Pulau Pinang
DR Chow TS
Dr Wee Hong Chin
Dr Kelvin Beh
Ms Ng Ru Shing
Ms Lim Yen Li
Mr Mak Wen Yao
Dr Wong Peng Shyan
Dr Leong Kar Nim
Dr Kang Kong Yeow
Dr Lee Kok Soon
Dr Carmen Koay Gaik Bee
Mr Chong Meng Fei
Mr Wong Kar Loon
HSBAS
Dr Low Lee
Lee
Dr Mohd Azri Mohd Suan
Dr Nadiah Hanim Zainul
Dr Ho Yi Bin
Dr Yeoh Chian Hui
Dr Hidayatil Alimi B Keya Nordin
Wong E-Jinq
Noor Syahireen Mohammed
Hospital Umum
Sarawak
Dr Chua HH
Dr Tong Xun Ting
Dr Andrew Chang Kean Wei
Dr Lim Han Hua
Dr Tonnii Sia Loong Loong
Dr Chew Lee Ping
Dr Yeo Leh Siang
Mdm Ngua Ching Zin
King Teck Long
Aylwin Lim Ming Wee
Shirin Tan Hui
Shirley Tan Siang Ning
Tiong Lee Len
Hosp Tuanku
Fauziah
Dr Suhaila
Dr Shafarul Halimi Mohamed
Dr Noor Hafini Abdul Sukur
Dr Wong Chee Kong
Dr Azri Nordin
Ms Alia Hayati Baharudin
Ang Wei Chern
Dr Amalina Anuar
Mdm Siti Ertina Asli
Dr John Yeo
Dr Chuah Seow Lin
Dr Benjamin Sachdev
Dr Vanusha
Dr Ng Chun Sien
Dr Abirami
Dr Nur Shairah Fatin
Dr Andy Ko
Dr Tay Kim Siang
HTAF
Dr Dzawanie
Dr Janattul Ain bt Jamal
Lim Bee Chiu
Dr Noorlina Binti Nordin
Dr Tan Sin Nee
Dr Evelyn Aun Su-yin
Dr Chiew Ken Seng
Dr Ng Kwang How
Dr Roenita bt. Baharudin
Dr Fariz Safhan Bin Mohamad
Nor
Dr Muhammad Zihni Abdullah
Dr Kiren Kaur
Che Wan Mohd Hafidz bin
Che Wan Ahmad
HQE
Dr Lee Heng Gee
Dr Nagarajan a/l Nagalingam
Dr Fong Kean Khang
Dr Khoo Thien Meng
Dr Jason Kong Henn Leong
Dr Saw Yen Tsen
Dr Lim Ming Yao
Mdm Juhanah Gimbo
Ms Teong Win Zee
Ms Norhaziah Mohamad
Salleh
Dr Wong Yiko
Dr Tan Yee Ann
Final results published in New England Journal of
Medicine Link: https://www.nejm.org/doi/full/10.1056/NEJMoa2023184
Innovations
•First study to allow virtual consent taking
•In real-time due to the infectious nature
of COVID-19
•Minimize exposure of investigators
•Without compromising GCP principles
•One of the largest trials on COVID-19
•Over 11k sample size globally
•Adaptive trial
•Fast-tracked trial approval mechanism
(record time)
Innovations
•All nations involved had regular meeting, initially
weekly, biweekly, and then monthly
•Zoom platform | Every Wednesday 9.30 pm
Malaysia time
•Discussed: issues, re-distribution of IP, ECRF
and sharing difficulties and success
•Monitoring: done by pharmacist and ICR monitor,
experienced and very stringent monitoring.
Innovations
● web based CRF and randomisation
● EDC castor
● required simple data
● eligibility
● consent upload
● choose IP that is available
● simple medical history
● classification of severity of disease
● randomised
● treatment outcome
Challenges
•Shipment of IMP to Malaysia was delayed due
to unforeseen circumstances
•Temperature excursion (interferon & HCQ)
•The batch was quarantined and not used
•Caused further delays in patient enrolment
•Trial administration challenges
•Time-zone difference with WHO Geneva
(scheduling difficulties)
•Coordinate large scale trial under MCO
Challenges
•Recruitment of cases:
•Busy settings
•Uploading consent – tech savvy
•Investigators concern : SOC vs IP
•Overcome :
•Regular discussion in team
•Sharing experience
What is the next step?
•Solidarity Plus
•Awaiting approval…
•More countries will be involved
HOPE
•Antiviral
•Anti inflammatory
•Monoclonal antibodies
Solidarity trial - challenges and success

Weitere ähnliche Inhalte

Was ist angesagt?

Introduction to Advance Qualitative Methods
Introduction to Advance Qualitative MethodsIntroduction to Advance Qualitative Methods
Introduction to Advance Qualitative MethodsKatrina Pritchard
 
Pre conception and prenatal diagnostic techniques
Pre conception and prenatal diagnostic techniquesPre conception and prenatal diagnostic techniques
Pre conception and prenatal diagnostic techniquesDr. Preksha Jain
 
Critical appraisal 2012 updated
Critical appraisal 2012 updatedCritical appraisal 2012 updated
Critical appraisal 2012 updatedsanghagirl
 
Clinical practice guidelines
Clinical practice guidelinesClinical practice guidelines
Clinical practice guidelinesabenedicto
 
Confidentiality in Healthcare
Confidentiality in HealthcareConfidentiality in Healthcare
Confidentiality in Healthcarekmasterson
 
Evidence Based Practice - EBP
Evidence Based Practice - EBPEvidence Based Practice - EBP
Evidence Based Practice - EBPSaira Ambreen
 
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...CHC Connecticut
 
Lecture 13 privacy, confidentiality and medical records
Lecture 13 privacy, confidentiality and medical recordsLecture 13 privacy, confidentiality and medical records
Lecture 13 privacy, confidentiality and medical recordsDr Ghaiath Hussein
 
Pet in gynecological malignancies
Pet in gynecological malignancies Pet in gynecological malignancies
Pet in gynecological malignancies ikramdr01
 
Proposed actions to improve waiting times at the emergency room
Proposed actions to improve waiting times at the emergency roomProposed actions to improve waiting times at the emergency room
Proposed actions to improve waiting times at the emergency roomXiomara Arias Fernandez
 
bolam case presentation
bolam case presentationbolam case presentation
bolam case presentationRai Shantanu
 
1 week 6 assignment ebp change process form ace star model
1 week 6 assignment  ebp change process form ace star model 1 week 6 assignment  ebp change process form ace star model
1 week 6 assignment ebp change process form ace star model SUKHI5
 
Medicolegal aspects in obstetrics
Medicolegal aspects in obstetricsMedicolegal aspects in obstetrics
Medicolegal aspects in obstetricsAziza Negm
 
Part 1 Introduction to Evidence-based Medicine Literature Searching
Part 1 Introduction to Evidence-based Medicine Literature SearchingPart 1 Introduction to Evidence-based Medicine Literature Searching
Part 1 Introduction to Evidence-based Medicine Literature SearchingImad Hassan
 
Patient satisfaction
Patient satisfactionPatient satisfaction
Patient satisfactionNc Das
 
Module 10 hiv-aids legal & ethical issues
Module 10   hiv-aids legal & ethical issuesModule 10   hiv-aids legal & ethical issues
Module 10 hiv-aids legal & ethical issuesDavid Ngogoyo
 
Endometrial Ablation
Endometrial AblationEndometrial Ablation
Endometrial AblationGalal Lotfi
 

Was ist angesagt? (20)

Introduction to Advance Qualitative Methods
Introduction to Advance Qualitative MethodsIntroduction to Advance Qualitative Methods
Introduction to Advance Qualitative Methods
 
Pre conception and prenatal diagnostic techniques
Pre conception and prenatal diagnostic techniquesPre conception and prenatal diagnostic techniques
Pre conception and prenatal diagnostic techniques
 
Critical appraisal 2012 updated
Critical appraisal 2012 updatedCritical appraisal 2012 updated
Critical appraisal 2012 updated
 
Clinical practice guidelines
Clinical practice guidelinesClinical practice guidelines
Clinical practice guidelines
 
Confidentiality in Healthcare
Confidentiality in HealthcareConfidentiality in Healthcare
Confidentiality in Healthcare
 
Evidence Based Practice - EBP
Evidence Based Practice - EBPEvidence Based Practice - EBP
Evidence Based Practice - EBP
 
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...
 
Lecture 13 privacy, confidentiality and medical records
Lecture 13 privacy, confidentiality and medical recordsLecture 13 privacy, confidentiality and medical records
Lecture 13 privacy, confidentiality and medical records
 
Pet in gynecological malignancies
Pet in gynecological malignancies Pet in gynecological malignancies
Pet in gynecological malignancies
 
Guidelines mpsg
Guidelines mpsgGuidelines mpsg
Guidelines mpsg
 
Proposed actions to improve waiting times at the emergency room
Proposed actions to improve waiting times at the emergency roomProposed actions to improve waiting times at the emergency room
Proposed actions to improve waiting times at the emergency room
 
Evidence Based Medicine_ppt
Evidence Based Medicine_pptEvidence Based Medicine_ppt
Evidence Based Medicine_ppt
 
bolam case presentation
bolam case presentationbolam case presentation
bolam case presentation
 
1 week 6 assignment ebp change process form ace star model
1 week 6 assignment  ebp change process form ace star model 1 week 6 assignment  ebp change process form ace star model
1 week 6 assignment ebp change process form ace star model
 
Medicolegal aspects in obstetrics
Medicolegal aspects in obstetricsMedicolegal aspects in obstetrics
Medicolegal aspects in obstetrics
 
Part 1 Introduction to Evidence-based Medicine Literature Searching
Part 1 Introduction to Evidence-based Medicine Literature SearchingPart 1 Introduction to Evidence-based Medicine Literature Searching
Part 1 Introduction to Evidence-based Medicine Literature Searching
 
Jci material
Jci materialJci material
Jci material
 
Patient satisfaction
Patient satisfactionPatient satisfaction
Patient satisfaction
 
Module 10 hiv-aids legal & ethical issues
Module 10   hiv-aids legal & ethical issuesModule 10   hiv-aids legal & ethical issues
Module 10 hiv-aids legal & ethical issues
 
Endometrial Ablation
Endometrial AblationEndometrial Ablation
Endometrial Ablation
 

Ähnlich wie Solidarity trial - challenges and success

Good Clinical Practice Principles 1.ppsx
Good Clinical Practice Principles 1.ppsxGood Clinical Practice Principles 1.ppsx
Good Clinical Practice Principles 1.ppsxFahdnaif2
 
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...Stephen Leiper
 
Early and late phase clinical trial potential and The Phase I Unit  projec...
Early and late phase clinical trial potential and  The Phase I Unit  projec...Early and late phase clinical trial potential and  The Phase I Unit  projec...
Early and late phase clinical trial potential and The Phase I Unit  projec...Tristan Azbej, PhD
 
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...KTN
 
The Future of Mobile Healthcare
The Future of Mobile Healthcare The Future of Mobile Healthcare
The Future of Mobile Healthcare Ruder Finn UK Ltd
 
Diagnostics: Challenges and Opportunities in the East Midlands
Diagnostics: Challenges and Opportunities in the East MidlandsDiagnostics: Challenges and Opportunities in the East Midlands
Diagnostics: Challenges and Opportunities in the East MidlandsNHS Improving Quality
 
MedicalResearch.com - Medical Research Interviews Week in Review
MedicalResearch.com - Medical Research Interviews Week in ReviewMedicalResearch.com - Medical Research Interviews Week in Review
MedicalResearch.com - Medical Research Interviews Week in ReviewMarie Benz MD FAAD
 
Star surg uk presentation
Star surg uk presentationStar surg uk presentation
Star surg uk presentationSTARSurg
 
North West London Research Symposium for health professions 2015
North West London Research Symposium for health professions 2015North West London Research Symposium for health professions 2015
North West London Research Symposium for health professions 2015Professor Priscilla Harries
 
TYA and Adult Late Effects Service at UCLH
TYA and Adult Late Effects Service at UCLHTYA and Adult Late Effects Service at UCLH
TYA and Adult Late Effects Service at UCLHUCLPartners
 
2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical TrailsKaren Radley
 
2014 07-08 Selectbio Biomarkers 2014, Cambridge
2014 07-08 Selectbio Biomarkers 2014, Cambridge2014 07-08 Selectbio Biomarkers 2014, Cambridge
2014 07-08 Selectbio Biomarkers 2014, CambridgeAlain van Gool
 
MedicalResearch.com - Medical Research Week in Review
MedicalResearch.com - Medical Research  Week in ReviewMedicalResearch.com - Medical Research  Week in Review
MedicalResearch.com - Medical Research Week in ReviewMarie Benz MD FAAD
 
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...Life Sciences Network marcus evans
 
Accelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 JuneAccelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 JuneInnovation Agency
 
Duchenne Research Breakthrough Fund review and update
Duchenne Research Breakthrough Fund review and update Duchenne Research Breakthrough Fund review and update
Duchenne Research Breakthrough Fund review and update Muscular Dystrophy Campaign
 

Ähnlich wie Solidarity trial - challenges and success (20)

Good Clinical Practice Principles 1.ppsx
Good Clinical Practice Principles 1.ppsxGood Clinical Practice Principles 1.ppsx
Good Clinical Practice Principles 1.ppsx
 
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
 
Enhanced Recovery Canada Presentation
Enhanced Recovery Canada PresentationEnhanced Recovery Canada Presentation
Enhanced Recovery Canada Presentation
 
Early and late phase clinical trial potential and The Phase I Unit  projec...
Early and late phase clinical trial potential and  The Phase I Unit  projec...Early and late phase clinical trial potential and  The Phase I Unit  projec...
Early and late phase clinical trial potential and The Phase I Unit  projec...
 
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
 
Introduction to Phase 2 & 3 Clinical Trials
Introduction to Phase 2 & 3 Clinical TrialsIntroduction to Phase 2 & 3 Clinical Trials
Introduction to Phase 2 & 3 Clinical Trials
 
The Future of Mobile Healthcare
The Future of Mobile Healthcare The Future of Mobile Healthcare
The Future of Mobile Healthcare
 
Diagnostics: Challenges and Opportunities in the East Midlands
Diagnostics: Challenges and Opportunities in the East MidlandsDiagnostics: Challenges and Opportunities in the East Midlands
Diagnostics: Challenges and Opportunities in the East Midlands
 
Interstitial Lung Disease (ILD) and Clinical trials
Interstitial Lung Disease (ILD) and Clinical trialsInterstitial Lung Disease (ILD) and Clinical trials
Interstitial Lung Disease (ILD) and Clinical trials
 
MedicalResearch.com - Medical Research Interviews Week in Review
MedicalResearch.com - Medical Research Interviews Week in ReviewMedicalResearch.com - Medical Research Interviews Week in Review
MedicalResearch.com - Medical Research Interviews Week in Review
 
Star surg uk presentation
Star surg uk presentationStar surg uk presentation
Star surg uk presentation
 
North West London Research Symposium for health professions 2015
North West London Research Symposium for health professions 2015North West London Research Symposium for health professions 2015
North West London Research Symposium for health professions 2015
 
TYA and Adult Late Effects Service at UCLH
TYA and Adult Late Effects Service at UCLHTYA and Adult Late Effects Service at UCLH
TYA and Adult Late Effects Service at UCLH
 
2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails
 
Clinical Trials 101
Clinical Trials 101Clinical Trials 101
Clinical Trials 101
 
2014 07-08 Selectbio Biomarkers 2014, Cambridge
2014 07-08 Selectbio Biomarkers 2014, Cambridge2014 07-08 Selectbio Biomarkers 2014, Cambridge
2014 07-08 Selectbio Biomarkers 2014, Cambridge
 
MedicalResearch.com - Medical Research Week in Review
MedicalResearch.com - Medical Research  Week in ReviewMedicalResearch.com - Medical Research  Week in Review
MedicalResearch.com - Medical Research Week in Review
 
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
 
Accelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 JuneAccelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 June
 
Duchenne Research Breakthrough Fund review and update
Duchenne Research Breakthrough Fund review and update Duchenne Research Breakthrough Fund review and update
Duchenne Research Breakthrough Fund review and update
 

Mehr von Institute for Clinical Research (ICR)

The Impact of COVID-19 Lockdown on Palliative Care Services in Malaysia
The Impact of COVID-19 Lockdown on Palliative Care Services in MalaysiaThe Impact of COVID-19 Lockdown on Palliative Care Services in Malaysia
The Impact of COVID-19 Lockdown on Palliative Care Services in MalaysiaInstitute for Clinical Research (ICR)
 
USE OF ARTIFICIAL INTELLIGENCE (DR.MATA SYSTEM) FOR THE DETECTION AND INTERVE...
USE OF ARTIFICIAL INTELLIGENCE (DR.MATA SYSTEM) FOR THE DETECTION AND INTERVE...USE OF ARTIFICIAL INTELLIGENCE (DR.MATA SYSTEM) FOR THE DETECTION AND INTERVE...
USE OF ARTIFICIAL INTELLIGENCE (DR.MATA SYSTEM) FOR THE DETECTION AND INTERVE...Institute for Clinical Research (ICR)
 
An introduction to Clinical Research Centre (CRC) Hospital Tuanku Fauziah
An introduction to Clinical Research Centre (CRC) Hospital Tuanku FauziahAn introduction to Clinical Research Centre (CRC) Hospital Tuanku Fauziah
An introduction to Clinical Research Centre (CRC) Hospital Tuanku FauziahInstitute for Clinical Research (ICR)
 
MHPSS Infographic - Strengthening Mental Health And Psychosocial Support Syst...
MHPSS Infographic - Strengthening Mental Health And Psychosocial Support Syst...MHPSS Infographic - Strengthening Mental Health And Psychosocial Support Syst...
MHPSS Infographic - Strengthening Mental Health And Psychosocial Support Syst...Institute for Clinical Research (ICR)
 
Strengthening Mental Health And Psychosocial Support Systems And Services For...
Strengthening Mental Health And Psychosocial Support Systems And Services For...Strengthening Mental Health And Psychosocial Support Systems And Services For...
Strengthening Mental Health And Psychosocial Support Systems And Services For...Institute for Clinical Research (ICR)
 
NIH Guidelines for Conducting Research in Ministry of Health (MOH) Institutio...
NIH Guidelines for Conducting Research in Ministry of Health (MOH) Institutio...NIH Guidelines for Conducting Research in Ministry of Health (MOH) Institutio...
NIH Guidelines for Conducting Research in Ministry of Health (MOH) Institutio...Institute for Clinical Research (ICR)
 

Mehr von Institute for Clinical Research (ICR) (20)

HKL Research Day 2023
HKL Research Day 2023HKL Research Day 2023
HKL Research Day 2023
 
The Impact of COVID-19 Lockdown on Palliative Care Services in Malaysia
The Impact of COVID-19 Lockdown on Palliative Care Services in MalaysiaThe Impact of COVID-19 Lockdown on Palliative Care Services in Malaysia
The Impact of COVID-19 Lockdown on Palliative Care Services in Malaysia
 
USE OF ARTIFICIAL INTELLIGENCE (DR.MATA SYSTEM) FOR THE DETECTION AND INTERVE...
USE OF ARTIFICIAL INTELLIGENCE (DR.MATA SYSTEM) FOR THE DETECTION AND INTERVE...USE OF ARTIFICIAL INTELLIGENCE (DR.MATA SYSTEM) FOR THE DETECTION AND INTERVE...
USE OF ARTIFICIAL INTELLIGENCE (DR.MATA SYSTEM) FOR THE DETECTION AND INTERVE...
 
15th National Conference for Clinical Research (NCCR)
15th National Conference for Clinical Research (NCCR)15th National Conference for Clinical Research (NCCR)
15th National Conference for Clinical Research (NCCR)
 
14th National Conference for Clinical Research 2021
14th National Conference for Clinical Research 202114th National Conference for Clinical Research 2021
14th National Conference for Clinical Research 2021
 
An introduction to Clinical Research Centre (CRC) Hospital Tuanku Fauziah
An introduction to Clinical Research Centre (CRC) Hospital Tuanku FauziahAn introduction to Clinical Research Centre (CRC) Hospital Tuanku Fauziah
An introduction to Clinical Research Centre (CRC) Hospital Tuanku Fauziah
 
Melaka Research Day 2023 Booklet
Melaka Research Day 2023 BookletMelaka Research Day 2023 Booklet
Melaka Research Day 2023 Booklet
 
CRC Perak Bulletin Issue 05
CRC Perak Bulletin Issue 05CRC Perak Bulletin Issue 05
CRC Perak Bulletin Issue 05
 
CRC Seremban Bulletin Issue 1 | January 2023
CRC Seremban Bulletin Issue 1 | January 2023CRC Seremban Bulletin Issue 1 | January 2023
CRC Seremban Bulletin Issue 1 | January 2023
 
PERTANDINGAN MENULIS NOTA HATI -BAHASAKU BANGSAKU DR AZIZ AMIR.pdf
PERTANDINGAN MENULIS NOTA HATI -BAHASAKU BANGSAKU DR AZIZ AMIR.pdfPERTANDINGAN MENULIS NOTA HATI -BAHASAKU BANGSAKU DR AZIZ AMIR.pdf
PERTANDINGAN MENULIS NOTA HATI -BAHASAKU BANGSAKU DR AZIZ AMIR.pdf
 
22 Years of Evolution: From NCRC To ICR
22 Years of Evolution: From NCRC To ICR22 Years of Evolution: From NCRC To ICR
22 Years of Evolution: From NCRC To ICR
 
PDU PKD Kinta - Perkhidmatan Doktor Udara (Flying Doctor Service)
PDU PKD Kinta - Perkhidmatan Doktor Udara (Flying Doctor Service)PDU PKD Kinta - Perkhidmatan Doktor Udara (Flying Doctor Service)
PDU PKD Kinta - Perkhidmatan Doktor Udara (Flying Doctor Service)
 
CRC SGH Newsletter Issue 52
CRC SGH Newsletter Issue 52CRC SGH Newsletter Issue 52
CRC SGH Newsletter Issue 52
 
MHPSS Infographic - Strengthening Mental Health And Psychosocial Support Syst...
MHPSS Infographic - Strengthening Mental Health And Psychosocial Support Syst...MHPSS Infographic - Strengthening Mental Health And Psychosocial Support Syst...
MHPSS Infographic - Strengthening Mental Health And Psychosocial Support Syst...
 
Strengthening Mental Health And Psychosocial Support Systems And Services For...
Strengthening Mental Health And Psychosocial Support Systems And Services For...Strengthening Mental Health And Psychosocial Support Systems And Services For...
Strengthening Mental Health And Psychosocial Support Systems And Services For...
 
CRC Seremban Bulletin Newsletter
CRC Seremban Bulletin NewsletterCRC Seremban Bulletin Newsletter
CRC Seremban Bulletin Newsletter
 
HFMD vs Monkeypox
HFMD vs Monkeypox HFMD vs Monkeypox
HFMD vs Monkeypox
 
MYLONGCOVID Study
MYLONGCOVID StudyMYLONGCOVID Study
MYLONGCOVID Study
 
Kajian MYLONGCOVID
Kajian MYLONGCOVIDKajian MYLONGCOVID
Kajian MYLONGCOVID
 
NIH Guidelines for Conducting Research in Ministry of Health (MOH) Institutio...
NIH Guidelines for Conducting Research in Ministry of Health (MOH) Institutio...NIH Guidelines for Conducting Research in Ministry of Health (MOH) Institutio...
NIH Guidelines for Conducting Research in Ministry of Health (MOH) Institutio...
 

Kürzlich hochgeladen

Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 

Kürzlich hochgeladen (20)

Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 

Solidarity trial - challenges and success

  • 1. •Challenges & Successes •Malaysia Experience •NMRR-20-686-54503 SOLIDARITY TRIAL Dr Chow Ting Soo
  • 2. Disclaimer •This slide was prepared for the Webinar Series Demystifying Clinical Trials & COVID-19 Updates session on 21st July 2021, by Dr Chow Ting Soo, Consultant Infectious Disease Physician, Penang General Hospital, Malaysia. •This is intended to share within healthcare professionals, not for public. •Kindly acknowledge “Clinical Updates in COVID-19 http://www.nih.gov.my/covid-19” should you plan to share the information obtained from this slide with your colleagues.
  • 3. Introduction Solidarity is an international clinical trial To identify effective treatment for COVID-19 Launched by the World Health Organization and partners Largest international randomized trials for COVID-19 treatments, enrolling almost 12 000 patients in 500 hospital sites in over 30 countries.
  • 4. What is Solidarity Trial? Multi centre , Open label , Randomised • HCQ • IFN • LPV/r • Remdesivir Evaluating the effect of drugs vs SOC: • mortality, • need for assisted ventilation and • duration of hospital stay. On 3 important outcomes in COVID-19 patients:
  • 5. Why does it work? Simplified trial procedures Once approval is obtained (regulatory and ethical), electronic entry of patients who have given informed consent Online randomization of consented patients (via a cloud-based GCP-compliant clinical data management system).
  • 6. Very special design : •Simple inclusion criteria •Confirmed COVID-19, hospitalized and consented •age ≥18 years, not known to have received any study drug, without anticipated transfer elsewhere within 72 hours, and, in their physician’s view, with no contra-indication to any study drug. •All severity •Except those critically ill (not able to survive in next 48 – 72H) •SOC : local guidelines
  • 7. Unique clinical trial •The Solidarity Trial is an adaptive trial. •This means that some unpromising drugs have been dropped and others will be added. •Hydroxychloroquine and lopinavir/ritonavir arms were discontinued on 20 June and 4 July 2020 respectively. •Interferon was dropped a month later •Remdesivir vs SOC
  • 8. Success •Streamlined trial initiation due to public emergency •Fastest ethics clearance by MREC (clearance given within five days, approved by a Full Board) •Fast-tracked CTIL clearance by NPRA (clearance given within seven days, evaluated by 8 reviewers from NPRA) •Study grant of RM81,000 was allocated for this study •Efficient IMP distribution to site (achieved within four days, facilitated by Ampang CRC)
  • 9. Trial timeline Project Activity Start End Status 1 MREC approval 06/04/2020 10/04/2020 Achieved 2 NPRA approval 10/04/2020 17/04/2020 Achieved 3 IMP distribution to Sites 4/5/2020 8/5/2020 Achieved
  • 10. Success •Great support from major hospitals •Nine major hospitals •MOH representative Datuk Dr Suresh Kumar+ 9 Principal investigators + •62 co-investigators •Facilitated by researchers Institute of Clinical Research •Total recruitment: 217 patients •63 remdesivir, 30 HCQ, 47 lopinavir/ritonavir, 5 interferon, 72 SOC
  • 11. Team member HSB DR Yasmin Gani Dr Tuang Wei Xuan Dr Vijayendran Rajalingam Dr Aruna Karthigayan Dr Sujana Leon Sean Saravanamuttu Dr Suvintheran Thangavelu Dr Syarifah Nurul Ain bt Syed Badaruddin Dr Swarna Lata Krishnabahawan Puan Rozila binti Harun Puan Hannah binti Md Mahir Dr Tharmini A/P Ravi Hospital KL DR Leong Chee Loon Dr Khairil Erwan Khalid Dr Rasidah bt Senian Dr Syed Sharif Anwar Aljafri Dr Suraya Hanim Abdullah Hashim Dr Shaharudeen bin Kamaludeen Dr Karina Koh Dr Lee Jen Ven Mohamad Ikram Zaki bin Jaafar Mak Woh Yon Sim Poh Pei Dr Nik Nur Eliza binti Mohamed
  • 12. Team member Hosp Melaka DR Nor Zaila Dr Shalini Vijayasingham Dr Tay Qin Le Dr Karamjit Kaur a/p Sarban Singh Dr Norlizam bin Mohd Nor @ Mat Nor Delarina Frimawati binti Othman Andu Dr Siti Hir Md Tahir Tay Eek Poei Seri Rabiatul Nur Binti Abu Salim Hospital Pulau Pinang DR Chow TS Dr Wee Hong Chin Dr Kelvin Beh Ms Ng Ru Shing Ms Lim Yen Li Mr Mak Wen Yao Dr Wong Peng Shyan Dr Leong Kar Nim Dr Kang Kong Yeow Dr Lee Kok Soon Dr Carmen Koay Gaik Bee Mr Chong Meng Fei Mr Wong Kar Loon
  • 13. HSBAS Dr Low Lee Lee Dr Mohd Azri Mohd Suan Dr Nadiah Hanim Zainul Dr Ho Yi Bin Dr Yeoh Chian Hui Dr Hidayatil Alimi B Keya Nordin Wong E-Jinq Noor Syahireen Mohammed Hospital Umum Sarawak Dr Chua HH Dr Tong Xun Ting Dr Andrew Chang Kean Wei Dr Lim Han Hua Dr Tonnii Sia Loong Loong Dr Chew Lee Ping Dr Yeo Leh Siang Mdm Ngua Ching Zin King Teck Long Aylwin Lim Ming Wee Shirin Tan Hui Shirley Tan Siang Ning Tiong Lee Len Hosp Tuanku Fauziah Dr Suhaila Dr Shafarul Halimi Mohamed Dr Noor Hafini Abdul Sukur Dr Wong Chee Kong Dr Azri Nordin Ms Alia Hayati Baharudin Ang Wei Chern Dr Amalina Anuar Mdm Siti Ertina Asli Dr John Yeo Dr Chuah Seow Lin Dr Benjamin Sachdev Dr Vanusha Dr Ng Chun Sien Dr Abirami Dr Nur Shairah Fatin Dr Andy Ko Dr Tay Kim Siang
  • 14. HTAF Dr Dzawanie Dr Janattul Ain bt Jamal Lim Bee Chiu Dr Noorlina Binti Nordin Dr Tan Sin Nee Dr Evelyn Aun Su-yin Dr Chiew Ken Seng Dr Ng Kwang How Dr Roenita bt. Baharudin Dr Fariz Safhan Bin Mohamad Nor Dr Muhammad Zihni Abdullah Dr Kiren Kaur Che Wan Mohd Hafidz bin Che Wan Ahmad HQE Dr Lee Heng Gee Dr Nagarajan a/l Nagalingam Dr Fong Kean Khang Dr Khoo Thien Meng Dr Jason Kong Henn Leong Dr Saw Yen Tsen Dr Lim Ming Yao Mdm Juhanah Gimbo Ms Teong Win Zee Ms Norhaziah Mohamad Salleh Dr Wong Yiko Dr Tan Yee Ann
  • 15. Final results published in New England Journal of Medicine Link: https://www.nejm.org/doi/full/10.1056/NEJMoa2023184
  • 16. Innovations •First study to allow virtual consent taking •In real-time due to the infectious nature of COVID-19 •Minimize exposure of investigators •Without compromising GCP principles •One of the largest trials on COVID-19 •Over 11k sample size globally •Adaptive trial •Fast-tracked trial approval mechanism (record time)
  • 17. Innovations •All nations involved had regular meeting, initially weekly, biweekly, and then monthly •Zoom platform | Every Wednesday 9.30 pm Malaysia time •Discussed: issues, re-distribution of IP, ECRF and sharing difficulties and success •Monitoring: done by pharmacist and ICR monitor, experienced and very stringent monitoring.
  • 18. Innovations ● web based CRF and randomisation ● EDC castor ● required simple data ● eligibility ● consent upload ● choose IP that is available ● simple medical history ● classification of severity of disease ● randomised ● treatment outcome
  • 19. Challenges •Shipment of IMP to Malaysia was delayed due to unforeseen circumstances •Temperature excursion (interferon & HCQ) •The batch was quarantined and not used •Caused further delays in patient enrolment •Trial administration challenges •Time-zone difference with WHO Geneva (scheduling difficulties) •Coordinate large scale trial under MCO
  • 20. Challenges •Recruitment of cases: •Busy settings •Uploading consent – tech savvy •Investigators concern : SOC vs IP •Overcome : •Regular discussion in team •Sharing experience
  • 21. What is the next step? •Solidarity Plus •Awaiting approval… •More countries will be involved